Prevalence of Genital HPV Infection in Males Following Introduction of Universal Male HPV Vaccination

This study will examine how common HPV infection is in teenage males in Australia before and after the introduction of universal school based vaccination of males in Australia.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Human Papillomavirus

Age range

17 year–19 year

Sex eligibility

Male

Study type

Observational

Primary location

Melbourne Sexual Health Centre

Melbourne, Victoria, 3053, Australia

About this study

Males aged 17 to 19 in Australia will be recruited from 2014. Men will undergo sampling from the penis for HPV. The prevalence of HPV infection will be determined in 2014-2015 and compared to the prevalence in 2016-2017.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Male
Aged 17 to 19
Able to complete study requirements
Residing in Australia from 12 years of age

Exclusion criteria

-Males reporting sex with males in the past 12 months

Treatment and study plan

Primary outcomes

Prevalence of Penile HPV Genotypes

Time frame: Single study visit (one time point per participant)

Prevalence of penile HPV genotypes among heterosexually active young men. Percentage of participants with specific genotypes on penile samples, as detected by Linear Array.

Participants provided a single penile sample.

Sponsors and collaborators

Lead sponsor

The Alfred

Other

Collaborators

Merck Sharp & Dohme LLC

Registry information

Acronym: Impress

Important dates

Study start: 2014
Primary completion: 2017
Study completion: 2017
First posted: Dec 6, 2013
Registry last updated: Mar 6, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed